BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22993286)

  • 1. Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults.
    Weissenborn K; Donnerstag F; Kielstein JT; Heeren M; Worthmann H; Hecker H; Schmitt R; Schiffer M; Pasedag T; Schuppner R; Tryc AB; Raab P; Hartmann H; Ding XQ; Hafer C; Menne J; Schmidt BM; Bültmann E; Haller H; Dengler R; Lanfermann H; Giesemann AM
    Neurology; 2012 Oct; 79(14):1466-73. PubMed ID: 22993286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.
    Magnus T; Röther J; Simova O; Meier-Cillien M; Repenthin J; Möller F; Gbadamosi J; Panzer U; Wengenroth M; Hagel C; Kluge S; Stahl RK; Wegscheider K; Urban P; Eckert B; Glatzel M; Fiehler J; Gerloff C
    Brain; 2012 Jun; 135(Pt 6):1850-9. PubMed ID: 22539260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.
    Braune SA; Wichmann D; von Heinz MC; Nierhaus A; Becker H; Meyer TN; Meyer GP; Müller-Schulz M; Fricke J; de Weerth A; Hoepker WW; Fiehler J; Magnus T; Gerloff C; Panzer U; Stahl RA; Wegscheider K; Kluge S
    Crit Care Med; 2013 Jul; 41(7):1702-10. PubMed ID: 23660733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.
    Frank C; Werber D; Cramer JP; Askar M; Faber M; an der Heiden M; Bernard H; Fruth A; Prager R; Spode A; Wadl M; Zoufaly A; Jordan S; Kemper MJ; Follin P; Müller L; King LA; Rosner B; Buchholz U; Stark K; Krause G;
    N Engl J Med; 2011 Nov; 365(19):1771-80. PubMed ID: 21696328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalamic involvement in patients with neurologic impairment due to Shiga toxin 2.
    Meuth SG; Göbel K; Kanyshkova T; Ehling P; Ritter MA; Schwindt W; Bielaszewska M; Lebiedz P; Coulon P; Herrmann AM; Storck W; Kohmann D; Müthing J; Pavenstädt H; Kuhlmann T; Karch H; Peters G; Budde T; Wiendl H; Pape HC
    Ann Neurol; 2013 Mar; 73(3):419-29. PubMed ID: 23424019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome.
    Schuppner R; Maehlmann J; Dirks M; Worthmann H; Tryc AB; Sandorski K; Bahlmann E; Kielstein JT; Giesemann AM; Lanfermann H; Weissenborn K
    Medicine (Baltimore); 2016 Feb; 95(6):e2337. PubMed ID: 26871766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry.
    Kielstein JT; Beutel G; Fleig S; Steinhoff J; Meyer TN; Hafer C; Kuhlmann U; Bramstedt J; Panzer U; Vischedyk M; Busch V; Ries W; Mitzner S; Mees S; Stracke S; Nürnberger J; Gerke P; Wiesner M; Sucke B; Abu-Tair M; Kribben A; Klause N; Schindler R; Merkel F; Schnatter S; Dorresteijn EM; Samuelsson O; Brunkhorst R;
    Nephrol Dial Transplant; 2012 Oct; 27(10):3807-15. PubMed ID: 23114903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.
    Vonberg RP; Höhle M; Aepfelbacher M; Bange FC; Belmar Campos C; Claussen K; Christner M; Cramer JP; Haller H; Hornef M; Fickenscher H; Fraedrich K; Knobloch JK; Kühbacher T; Manns MP; Nitschke M; Peters G; Pulz M; Rohde H; Roseland RT; Sayk F; Schaumburg F; Schöcklmann HO; Schubert S; Solbach W; Karch H; Suerbaum S
    Clin Infect Dis; 2013 Apr; 56(8):1132-40. PubMed ID: 23300241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli 0111.
    Azadi R; Calabrese K; Stroup J
    J Am Osteopath Assoc; 2010 Sep; 110(9):538-44. PubMed ID: 20876839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak.
    Piercefield EW; Bradley KK; Coffman RL; Mallonee SM
    Arch Intern Med; 2010 Oct; 170(18):1656-63. PubMed ID: 20937925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.
    Nielsen S; Frank C; Fruth A; Spode A; Prager R; Graff A; Plenge-Bönig A; Loos S; Lütgehetmann M; Kemper MJ; Müller-Wiefel DE; Werber D
    Zoonoses Public Health; 2011 Dec; 58(8):567-72. PubMed ID: 21824358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006.
    Gould LH; Demma L; Jones TF; Hurd S; Vugia DJ; Smith K; Shiferaw B; Segler S; Palmer A; Zansky S; Griffin PM
    Clin Infect Dis; 2009 Nov; 49(10):1480-5. PubMed ID: 19827953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values.
    López EL; Contrini MM; Glatstein E; Ayala SG; Santoro R; Ezcurra G; Teplitz E; Matsumoto Y; Sato H; Sakai K; Katsuura Y; Hoshide S; Morita T; Harning R; Brookman S
    Pediatr Infect Dis J; 2012 Jan; 31(1):20-4. PubMed ID: 21829137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemolytic uremic syndrome in children of Mendoza, Argentina: association with Shiga toxin-producing Escherichia coli infection].
    Rivas M; Balbi L; Miliwebsky ES; García B; Tous MI; Leardini NA; Prieto MA; Chillemi GM; de Principi ME
    Medicina (B Aires); 1998; 58(1):1-7. PubMed ID: 9674201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric symptoms in patients with Shiga toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome.
    Kleimann A; Toto S; Eberlein CK; Kielstein JT; Bleich S; Frieling H; Sieberer M
    PLoS One; 2014; 9(7):e101839. PubMed ID: 25007072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolytic-uremic syndrome associated with an infection by verotoxin producing Escherichia coli 0111 in a woman on oral contraceptives.
    Stenger KO; Windler F; Karch H; von Wulffen H; Heesemann J
    Clin Nephrol; 1988 Mar; 29(3):153-8. PubMed ID: 3282732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial.
    Greinacher A; Friesecke S; Abel P; Dressel A; Stracke S; Fiene M; Ernst F; Selleng K; Weissenborn K; Schmidt BM; Schiffer M; Felix SB; Lerch MM; Kielstein JT; Mayerle J
    Lancet; 2011 Sep; 378(9797):1166-73. PubMed ID: 21890192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hemolytic uremic syndrome with daily bowel lavage in patients with Shiga toxin-producing enterohemorrhagic Escherichia coli O104:H4 infection.
    Lüth S; Fründt TW; Rösch T; Schlee C; Lohse AW
    JAMA Intern Med; 2014 Jun; 174(6):1003-5. PubMed ID: 24781800
    [No Abstract]   [Full Text] [Related]  

  • 20. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.
    Valles PG; Pesle S; Piovano L; Davila E; Peralta M; Principi I; Lo Giudice P
    Medicina (B Aires); 2005; 65(5):395-401. PubMed ID: 16296634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.